Does the Key to Curing Alzheimer’s and Rare Childhood Disease–RCDP–Lie in Plasmalogens?

Could Plasmalogen Treatment Results for RCDP* Signal Hope for Alzheimer’s Sufferers?

Fifteen years of neuroscientific research led Dr Dayan Goodenowe to a landmark discovery – a single molecule much lower than normal in the blood of people with Alzheimer’s Disease. Using his own technology, he identified that molecule ...